GAGANDEEP MUNDI: Open Payments
NPI 1124748363 · LYNNWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 63 payments from 12 companies in 2025. Trend: 2023 $205 · 2024 $957 · 2025 $1,883
Food & beverage: $1,782Education: $101
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $322 |
| Teva Pharmaceuticals USA, Inc. | 9 | $283 |
| ABBVIE INC. | 9 | $271 |
| Axsome Therapeutics, Inc. | 3 | $174 |
| Tris Pharma Inc | 3 | $143 |
| Alkermes, Inc. | 6 | $139 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| E.R. Squibb & Sons, L.L.C. | 3 | $121 |
| Neurocrine BioSciences, Inc. | 3 | $111 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
Products named: CAPLYTA, VRAYLAR, Auvelity, AUSTEDO XR, Dyanavel XR, ARISTADA, COBENFY, INGREZZA.
Industry payments across WA — which companies pay providers there.
